Search Results - Pollutri, D

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma

    MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma by Pollutri, D, Fornari, F, Turato, C, Villano, G, Quarta, S, Ruvoletto, M, Bolondi, L, Gramantieri, L, Pontisso, P

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance

    In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance by Pollutri, D, Patrizi, C, Marinelli, S, Ferracin, M, Negrini, M, Toaldo, M. Baron, Bolondi, L, Gramantieri, L, Fornari, F

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    933 MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT

    933 MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT by Fornari, F, Gramantieri, L, Milazzo, M, Pollutri, D, Grazi, G.L, Negrini, M, Bolondi, L

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    34 MicroRNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT

    34 MicroRNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT by Fornari, F, Gramantieri, L, Milazzo, M, Pollutri, D, Grazi, G.L, Negrini, M, Bolondi, L

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    MicroRNA-199a-3p targets mTOR in human hepatocellular carcinoma

    MicroRNA-199a-3p targets mTOR in human hepatocellular carcinoma by Fornari, F, Gramantieri, L, Pollutri, D, Veronese, A, Grazi, G.L, Negrini, M, Bolondi, L

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    PO-1665: The mesorectum motion using MR-guided Radiotherapy: an exploratory study to quantify PTV margins

    PO-1665: The mesorectum motion using MR-guided Radiotherapy: an exploratory study to quantify PTV margins by Romano, A., Chiloiro, G., Boldrini, L., Cusumano, D., Placidi, L., Antonelli, M.V., Pollutri, V., Votta, C., Gambacorta, M.A., Valentini, V.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PO-1604: Quantitative analysis of treatment process time for MRI-LINAC system gating efficiency optimization

    PO-1604: Quantitative analysis of treatment process time for MRI-LINAC system gating efficiency optimization by Placidi, L., Pollutri, V., Votta, C., Cusumano, D., Boldrini, L., Chiloiro, G., Azario, L., De Spirito, M., Valentini, V.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    PD-0069: Use of prescription isodose boundary to optimise treatment delivery during MR-guided Radiotherapy

    PD-0069: Use of prescription isodose boundary to optimise treatment delivery during MR-guided Radiotherapy by Votta, C., Cusumano, D., Boldrini, L., Pollutri, V., Placidi, L., Chiloiro, G., Romano, A., Antonelli, M.V., Valentini, V.

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    PH-0492 Modesty in breast cancer patients during radiotherapy: interim results of a multicentric study

    PH-0492 Modesty in breast cancer patients during radiotherapy: interim results of a multicentric study by Boldrini, L., Elia, C., Pollutri, V., Dinapoli, L., Caliandro, M., Manfrida, S., Masiello, V., Chieffo, D., Balducci, M., Marazzi, F., Gregucci, F., Gambacorta, M.A., Colangione, S.P., Fiorentino, A., Valentini, V.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: